Mette Tiedemann Skipper

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 88 citations · Full text

Evaluation of platelet function in thrombocytopenia

Mette Tiedemann Skipper, Peter Rubak, Jesper Stentoft et al. · Platelets · 2017 · 46 citations · Full text

Thrombocytopenia model with minimal manipulation of blood cells allowing whole blood assessment of platelet function

Mette Tiedemann Skipper, Peter Rubak, Ole H. Larsen et al. · Platelets · 2015 · 30 citations · Full text

Whole blood platelet aggregation determined by the ROTEM platelet equipment; reference intervals and stability

Peter H. Nissen, Mette Tiedemann Skipper, Anne‐Mette Hvas · Platelets · 2019 · 18 citations · Full text

National, clinical cohort study of late effects among survivors of acute lymphoblastic leukaemia: the ALL-STAR study protocol

Liv Andrés‐Jensen, Mette Tiedemann Skipper, Kristian Mielke Christensen et al. · BMJ Open · 2021 · 17 citations · Full text